668 results on '"Kilpatrick, Trevor"'
Search Results
2. Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
3. Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system
4. Antigen-specific immunotherapy via delivery of tolerogenic dendritic cells for multiple sclerosis
5. High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS
6. White matter tract conductivity is resistant to wide variations in paranodal structure and myelin thickness accompanying the loss of Tyro3: an experimental and simulated analysis
7. Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study
8. Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
9. Development of [18F]MIPS15692, a radiotracer with in vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease
10. Evidence for decreased copper associated with demyelination in the corpus callosum of cuprizone-treated mice
11. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome
12. The Tolerogenic Influence of Dexamethasone on Dendritic Cells Is Accompanied by the Induction of Efferocytosis, Promoted by MERTK
13. The therapeutic effect of GAS6 in remyelination is dependent upon Tyro3.
14. Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
15. HLA-DRB1*15:01 and the MERTK Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MS.
16. The oligodendrocyte-enriched orphan G protein-coupled receptor Gpr62 is dispensable for central nervous system myelination
17. Patient‐determined disease steps is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis
18. Nanodiamonds with silicon vacancy defects for non-toxic photostable fluorescent labeling of neural precursor cells
19. The clinical profile of NMOSD in Australia and New Zealand
20. Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
21. The Patient‐Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.
22. Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study.
23. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
24. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study
25. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
26. Multiple Sclerosis: Basic and Clinical
27. DNA methylation signatures of Multiple Sclerosis occur independently of genetic risk and are primarily attributed to B cells and monocytes
28. Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein–Barr virus.
29. DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.
30. EphA4 (Sek1) Receptor Tyrosine Kinase is Required for the Development of the Corticospinal Tract
31. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity
32. Cell Death in the Schwann Cell Lineage and its Regulation by Neuregulin
33. Comparative effectiveness of autologous hematopoietic stem cell transplant vs Fingolimod, Natalizumab, and Ocrelizumab in highly active relapsing-remitting multiple sclerosis
34. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.
35. Higher consumption of ultra-processed foods and increased likelihood of central nervous system demyelination in a case-control study of Australian adults.
36. Early predictors of visual and axonal outcomes after acute optic neuritis
37. 2326 Differential methylation mediates significant proportions of environmental and lifestyle factors’ associations with MS risk: results from the Ausimmune case-control study
38. 2413 Does serum neurofilament light chain level contribute to the prediction of treatment response in multiple sclerosis?
39. 2367 Developing tolerogenic dendritic cells as immunotherapy for multiple sclerosis
40. Microglial Function in MS Pathology
41. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies
42. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations
43. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy
44. Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration In Vitro Acutely Influences Monocyte Differentiation but Not Microglial Activation
45. Clinical impact of whole-genome sequencing in patients with early-onset dementia
46. Mouse microglia express unique miRNA-mRNA networks to facilitate age-specific functions in the developing central nervous system
47. Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic
48. Gait stability reflects motor tracts damage at early stages of multiple sclerosis
49. Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination
50. Achievements and obstacles of remyelinating therapies in multiple sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.